All In MedTech

FDA Clearance Tracker · K252163

Elecsys Phospho-Tau (181P) Plasma

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Oct 8, 2025 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Oct 8, 2025

Substantially Equivalent

Time to decision

90 days

Received Jul 10, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K252163
Device name
Elecsys Phospho-Tau (181P) Plasma
Applicant location
Indianapolis, IN
Received
Jul 10, 2025
Decided
Oct 8, 2025
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 866.5840

Every decision under product code SET

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code SET. The earliest in FDA's data is K242706, decided May 16, 2025.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Roche Diagnostics

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.